
Nordic Countries
Need information ?
Contact us
You are here
News
bioMérieux receives Emergency Use Authorization for BIOFIRE® COVID-19 test
24 March, 2020bioMérieux, a world leader in the field of in vitro diagnostics, today announced that its subsidiary, BioFire Defense, has received Emergency Use Authorization by the U.S. Food and Drug Administration of its BIOFIRE® COVID-19 test for use in CLIA moderate and high complexity clinical...